Edition:
United Kingdom

Strides Shasun Ltd (STSA.NS)

STSA.NS on National Stock Exchange of India

808.50INR
10:21am GMT
Change (% chg)

Rs7.15 (+0.89%)
Prev Close
Rs801.35
Open
Rs803.10
Day's High
Rs821.75
Day's Low
Rs802.25
Volume
371,441
Avg. Vol
524,650
52-wk High
Rs1,274.70
52-wk Low
Rs752.30

Select another date:

Mon, Dec 4 2017

BRIEF-Eris Lifesciences Says ‍Divestment Of Strides Shasun's India Brand Business To Co Completed

* SAYS ‍DIVESTMENT OF STRIDES SHASUN'S INDIA BRAND BUSINESS TO CO COMPLETED Source text - http://bit.ly/2kkCPEo Further company coverage:

BRIEF-Strides Shasun gets U.S. FDA approval for acetazolamide tablets​

* Says product to be marketed by Strides Pharma Inc in the US market‍​ Source text for Eikon: Further company coverage:

BRIEF-Strides Shasun approves scheme of amalgamation for merger of units with co‍​

* Says approved scheme of amalgamation for merger of units Arrow Remedies, Fagris Medica, Strides Chemicals with co‍​ Source text - http://bit.ly/2A2odNz Further company coverage:

BRIEF-India's Strides Shasun Sept-qtr consol profit down 87 pct

* Sept quarter consol net profit 107.3 million rupees versus profit of 854.3 million rupees last year

BRIEF-Strides Shasun gets U.S. FDA approval for omega-3-acid ethyl esters capsules

* Says Strides Shasun receives USFDA approval for omega-3-acid ethyl esters capsules

BRIEF-Strides Shasun gets shareholders' nod for appointment of Shashank Sinha as MD

* Gets shareholders' nod for appointment of Shashank Sinha as MD Source text: http://bit.ly/2x75CQP Further company coverage:

BRIEF-India's Strides Shasun gets U.S. FDA nod for potassium citrate extended-release tablets

* Says receives USFDA approval for potassium citrate extended-release tablets

BRIEF-Strides Shasun seeks shareholders' nod for appointment of Shashank Sinha as MD

* Seeks shareholders' nod for appointment of Shashank Sinha as MD Source text - http://bit.ly/2v8XIHt Further company coverage:

BRIEF-India's Strides Shasun June-qtr consol profit falls

* June quarter consol profit 57.8 million rupees versus 324.7 million rupees last year

BRIEF-Strides Shasun gets USFDA approval for cetirizine softgel capsules

* Says receives USFDA approval for cetirizine softgel capsules

Select another date: